Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?

Mahmoud M A Mohamed; Ismail Amr El-Shimy; Muhammad Abdul Hadi

doi:10.1186/s13054-020-03023-0

Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?

Mahmoud M A Mohamed, Ismail Amr El-Shimy, Muhammad Abdul Hadi

Pharmacy

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

207 Downloads (Pure)

Original language	English
Article number	311
Journal	Critical care (London, England)
Volume	24
Issue number	1
DOIs	https://doi.org/10.1186/s13054-020-03023-0
Publication status	Published - 8 Jun 2020

Keywords

Clinical Trials as Topic
Coronavirus Infections/complications
Hospitalization
Humans
Pandemics
Pneumonia, Viral/complications
Proteinase Inhibitory Proteins, Secretory/therapeutic use
Respiratory Distress Syndrome, Adult/drug therapy
Severity of Illness Index
Treatment Outcome

Access to Document

10.1186/s13054-020-03023-0Licence: Creative Commons: Attribution (CC BY)

Mohamed_et_al_2020_Neutrophil_elastase_inhibitors_Critical_CareFinal published version, 348 KBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{e6fe2ab6e8cd42839bae640f14323c94,

title = "Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?",

keywords = "Clinical Trials as Topic, Coronavirus Infections/complications, Hospitalization, Humans, Pandemics, Pneumonia, Viral/complications, Proteinase Inhibitory Proteins, Secretory/therapeutic use, Respiratory Distress Syndrome, Adult/drug therapy, Severity of Illness Index, Treatment Outcome",

author = "Mohamed, {Mahmoud M A} and El-Shimy, {Ismail Amr} and Hadi, {Muhammad Abdul}",

year = "2020",

month = jun,

day = "8",

doi = "10.1186/s13054-020-03023-0",

language = "English",

volume = "24",

journal = "Critical care (London, England)",

issn = "1466-609X",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Neutrophil Elastase Inhibitors

T2 - A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?

AU - Mohamed, Mahmoud M A

AU - El-Shimy, Ismail Amr

AU - Hadi, Muhammad Abdul

PY - 2020/6/8

Y1 - 2020/6/8

KW - Clinical Trials as Topic

KW - Coronavirus Infections/complications

KW - Hospitalization

KW - Humans

KW - Pandemics

KW - Pneumonia, Viral/complications

KW - Proteinase Inhibitory Proteins, Secretory/therapeutic use

KW - Respiratory Distress Syndrome, Adult/drug therapy

KW - Severity of Illness Index

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85086296918&partnerID=8YFLogxK

U2 - 10.1186/s13054-020-03023-0

DO - 10.1186/s13054-020-03023-0

M3 - Article

C2 - 32513225

SN - 1466-609X

VL - 24

JO - Critical care (London, England)

JF - Critical care (London, England)

IS - 1

M1 - 311

ER -